LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

First Ever Prototype Applies AI to Colorectal Diagnosis

By LabMedica International staff writers
Posted on 08 Mar 2024
Print article
Image: The prototype uses AI as a complementary tool to the diagnosis of colon and rectal biopsies (Photo courtesy of INESC TEC)
Image: The prototype uses AI as a complementary tool to the diagnosis of colon and rectal biopsies (Photo courtesy of INESC TEC)

The incidence and mortality rates of colorectal cancer (CRC) are on an alarming rise, with predictions showing a continuous increase until at least 2040. Currently, CRC ranks as the third most diagnosed (10.7% of all cancer cases) and the second deadliest cancer type. Despite the effectiveness of imaging and endoscopic techniques in CRC detection, the final cancer diagnosis always relies on a pathologist's assessment of histological samples. Grading dysplasia is still routinely performed by pathologists worldwide when assessing colorectal tissue samples. Computer-aided diagnosis (CAD) systems for colorectal pathology face challenges due to the high data volume and the massive resolution of images, leading to a bottleneck in deep learning (DL) approaches that extract patches from the whole slides.

Now, researchers at INESC TEC (Porto, Portugal) and IMP Diagnostics (Porto, Portugal) have created a pioneering prototype that employs artificial intelligence (AI) for colorectal diagnosis. This prototype is a result of a technical innovation involving a new, more efficient training methodology that significantly reduces the number of images needed to train the AI model without compromising its effectiveness. The advancement not only enhances image analysis technology but also contributes to developing more efficient solutions for diagnosing colorectal cancer. The project focused on enhancing a prototype that utilizes AI as a supplementary tool for diagnosing colon and rectal biopsies and creating the most extensive digital image database of colorectal pathologies, now freely available for research and knowledge advancement.

This model was trained using approximately 10,000 images of tissues affected by colorectal pathology, achieving a diagnostic accuracy of 93.44% and a sensitivity of 99.7% in identifying high-risk lesions associated with this cancer type. Over half (5,300) of these images, amounting to nearly five terabytes of data, have been made accessible to the scientific community. The distribution of these digital images is part of IMP Diagnostics and INESC TEC's commitment to science promotion and scientific knowledge sharing, adhering to the FAIR principles. These international guidelines recommend that scientific data should be easily findable, accessible, interoperable, and reusable.

Pedro Neto, a researcher at INESC TEC, stated that “part of the images can be used to train other AI models, while the others will be used specifically for testing/benchmarking between AI tools – towards improving thoroughness and fairness when comparing said tools”.

Related Links:
INESC TEC
IMP Diagnostics

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more